(VVOS) Vivos Therapeutics - Performance 118.3% in 12m
VVOS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-69.14%
#145 in Peer-Group
Rel. Strength
94.76%
#404 in Stock-Universe
Total Return 12m
118.34%
#9 in Peer-Group
Total Return 5y
-97.72%
#184 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 5.95 USD |
| 52 Week Low | 2.04 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 97.91 |
| Buy/Sell Signal +-5 | 0.07 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: VVOS (118.3%) vs XLV (-4.8%)
5y Drawdown (Underwater) Chart
Top Performer in Health Care Equipment
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| STE NYSE STERIS |
-4.17% | 6.85% | 61.8% | 38.8 | 24 | 1.95 | 64.0% | 69.1% |
| ITGR NYSE Integer Holdings |
-3.19% | 2.1% | 77.8% | 56.3 | 21.7 | 0.94 | 39.6% | -28.7% |
| RMD NYSE ResMed |
2.24% | 34.2% | 39.3% | 28.8 | 24.7 | 1.53 | 88.9% | 16.9% |
| SHL XETRA Siemens Healthineers |
0.64% | -10.7% | 22.4% | 25.2 | 18.4 | 1.12 | 12.9% | 7.65% |
| DEMANT CO Demant |
-3.74% | -10.4% | 44.3% | 20.1 | 19.8 | 0.95 | -3.70% | 7% |
| GMED NYSE Globus Medical |
-6.2% | -17.5% | 23.5% | 44.9 | 18.9 | 1.72 | -16.6% | 7.79% |
| SOON SW Sonova H |
-8.64% | -13.8% | 25.7% | 26.6 | 19.5 | 1.76 | 35.7% | 36.3% |
| DRW3 XETRA Drägerwerk & Co. KGaA |
-8.33% | 33.5% | -7.69% | 10.7 | - | 1.46 | -14.1% | -19.6% |
Performance Comparison: VVOS vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for VVOS
| Total Return (including Dividends) | VVOS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 139.25% | 1.09% | 3.75% |
| 3 Months | 129.60% | 1.98% | 25.32% |
| 12 Months | 118.34% | -4.84% | 13.11% |
| 5 Years | -97.72% | 45.05% | 109.78% |
| Trend Score (consistency of price movement) | VVOS | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 94.2% | 20.4% | 80.3% |
| 3 Months | 30.5% | -22.1% | 97.2% |
| 12 Months | 11.6% | -76.5% | 45.4% |
| 5 Years | -95.4% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th100.00 | 136.67% | 130.60% |
| 3 Month | %th96.00 | 125.14% | 83.21% |
| 12 Month | %th96.50 | 129.45% | 93.03% |
| 5 Years | %th9.50 | -98.25% | -98.74% |
FAQs
Does Vivos Therapeutics (VVOS) outperform the market?
Yes,
over the last 12 months VVOS made 118.34%, while its related Sector, the Health Care Sector SPDR (XLV) made -4.84%.
Over the last 3 months VVOS made 129.60%, while XLV made 1.98%.
Performance Comparison VVOS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
VVOS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 31.9% | 135.5% | 11.3% | 105% |
| US NASDAQ 100 | QQQ | 31.3% | 135.1% | 9.7% | 107% |
| German DAX 40 | DAX | 30% | 139.1% | -1.5% | 88% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 30.8% | 135.5% | 7.6% | 97% |
| Hongkong Hang Seng | HSI | 32.3% | 136.2% | -9.2% | 79% |
| India NIFTY 50 | INDA | 32.6% | 138.4% | 10.7% | 119% |
| Brasil Bovespa | EWZ | 32.6% | 133.4% | -10.7% | 111% |
VVOS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 33.2% | 135.7% | 6.8% | 94% |
| Consumer Discretionary | XLY | 32.6% | 137.3% | 19.1% | 102% |
| Consumer Staples | XLP | 33.1% | 138.9% | 10.8% | 110% |
| Energy | XLE | 28.7% | 132.5% | 15% | 116% |
| Financial | XLF | 33.2% | 136.5% | 8.7% | 90% |
| Health Care | XLV | 33.6% | 138.2% | 20.2% | 123% |
| Industrial | XLI | 31.7% | 136.1% | 4.4% | 94% |
| Materials | XLB | 31% | 135.5% | 7.7% | 113% |
| Real Estate | XLRE | 33% | 139.4% | 12.4% | 107% |
| Technology | XLK | 30.2% | 132.1% | 7.2% | 108% |
| Utilities | XLU | 33.3% | 138% | 8.9% | 97% |
| Aerospace & Defense | XAR | 31.2% | 135.5% | -6.9% | 70% |
| Biotech | XBI | 30.3% | 138.7% | 25.4% | 127% |
| Homebuilder | XHB | 33.1% | 133.3% | 19.2% | 115% |
| Retail | XRT | 31.8% | 137.7% | 16% | 109% |
VVOS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 28.2% | 132% | 17.6% | 123% |
| Natural Gas | UNG | 34.2% | 149.7% | 30.5% | 125% |
| Gold | GLD | 33.4% | 140.1% | -6.6% | 79% |
| Silver | SLV | 30.6% | 139.6% | -4.3% | 100% |
| Copper | CPER | 25.3% | 129.2% | -9.1% | 100% |
VVOS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 34.7% | 138.2% | 15% | 122% |
| iShares High Yield Corp. Bond | HYG | 32.5% | 138% | 12.9% | 109% |